(1,3)glucans in innate immunity. mammalian systems

Chemistry, Biochemistry, and Biology of 1-3 Beta Glucans and Related Polysaccharides

Volumn , Issue , 2009, Pages 579-619

  Brown, Gordon D ^a   Williams, David L ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857103811     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373971-1.00018-2     Document Type: Chapter

References (209)

1. Adachi Y., Ishii T., Ikeda Y., Hoshino A., Tamura H., Aketagawa J., Tanaka S., Ohno N. Characterization of beta--lucan recognition site on C--ype lectin, Dectin 1. Infection and Immunity 2004, 72:4159--171.
2. Adachi Y., Ohno N., Ohsawa M., Sato K.d., Oikawa S., Toshiro Y. Physicochemical properties and antitumor activities of chemically modified derivatives of antitumor glucan "Grifolan LE" from Grifola frondosa. Chemical and Pharmaceutical Bulletin 1989, 37:1838--843.
3. Adams E.L., Rice P.J., Graves B., Ensley H.E., Yu H., Brown G.D., Gordon S., Monteiro M.A., Papp--zabo E., Lowman D.W., Power T.D., Wempe M.F., Williams D.L. Differential high affinity interaction of Dectin-- with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side chain branching. Journal of Pharmacolology and Experimental Therapeutics 2008, Epub ahead of print.
4. Aoki T., Kaneko Y., Nguyen T., Stefanski M.S., Ting R.C., Manak M.M. Curdlan sulfate and HIV--: II. In vitro long--erm treatment of HIV-- infection with curdlan sulfate. AIDS Research and Human Retroviruses 1992, 8:605--12.
5. Aoki T., Kaneko Y., Stefanski M.S., Nguyen T., Ting R.C. Curdlan sulfate and HIV--. I. In vitro inhibitory effects of curdlan sulfate on HIV-- infection. AIDS Research and Human Retroviruses 1991, 7:409--15.
6. Araujo--ilho I., Rego A.C., Pinheiro L.A., Azevedo I.M., Medeiros V.B., Brandao--eto J., Medeiros A.C. Prevention of bacterial translocation using beta--1--)----lucan in small bowel ischemia and reperfusion in rats. Acta cirúrgica brasileira 2006, 21:18--2.
7. Ariizumi K., Shen G.--., Shikano S., Xu S., Ritter R.I., Kumamoto T., Edelbaum D., Morita A., Bergstresser P.R., Takashima A. Identification of a novel, dendritic cell--ssociated molecule, Dectin--, by subtractive cDNA cloning. Journal of Biological Chemistry 2000, 275:20157--0167.
8. Babineau T.J., Hackford A., Kenler A., Bistrian B., Forse R.A., Fairchild P.G., Heard S., Keroack M., Causha P., Benotti P. A Phase II multicenter, double--lind, randomized, placebo--ontrolled study of three dosages of an immunomodulator (pgg--lucan) in high--isk surgical patients. Archives of Surgery 1994, 129:1204--210.
9. Babineau T.J., Marcello P., Swails W., Kenler A., Bistrian B., Forse R.A. Randomized phase I/II trial of a macrophage--pecific immunomodulator (PGG--lucan) in high--isk surgical patients. Annals of Surgery 1994, 220:601--09.
10. Backer, R., van Leeuwen, F., Kraal, G., & den Haan, J. M. (2008). CD8(-- dendritic cells preferentially cross--resent Saccharomyces cerevisiae antigens. European Journal of Immunology. Epub ahead of print.
11. Baran J., Allendorf D.J., Hong F., Ross G.D. Oral beta--lucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell--ediated immune response in mammary tumor--earing mice. Folia histochemica et cytobiologica 2007, 45:107--14.
12. Barry W.H. Mechanisms of immune--ediated myocyte injury. Circulation 1994, 89:2421--432.
13. Battle J., Ha T., Li C., Della Beffa V., Rice P., Kalbfleisch J., Browder W., Williams D. Ligand binding to the (1→3)--eta----lucan receptor stimulates NFΚB activation, but not apoptosis in U937 cells. Biochemical and Biophysical Research Communications 1998, 249:499--04.
14. Bayrak O., Turgut F., Karatas O.F., Cimentepe E., Bayrak R., Catal F., Atis O., Akcay A., Unal D. Oral beta--lucan protects kidney against ischemia/reperfusion injury in rats. American Journal of Nephrology 2008, 28:190--96.
15. Berdal M., Appelbom H.I., Eikrem J.H., Lund A., Zykova S., Busund L.T., Seljelid R., Jenssen T. Aminated beta--,3----lucan improves wound healing in diabetic db/db mice. Wound Repair and Regeneration 2007, 15:825--32.
16. Bohn J.A., BeMiller J.N. (1--)--eta----lucans as biological response modifiers: a review of structure--unctional activity relationships. Carbohydrate Polymers 1995, 28:3--4.
17. Bolcal C., Yildirim V., Doganci S., Sargin M., Aydin A., Kuralay E., Ozal E., Demirkilic U., Oz B.S., Sayal A., Tatar H. Do n--cetylcystein, beta--lucan, and coenzyme A10 mollify myocardial ischemia--eperfusion injury?. The heart surgery forum 2007, 10:E222--227.
18. Bozkurt B., Jribb S.B., Clubb F.J., Michael L.H., Didenko V.V., Hornsby P.J., Yukihiro S., Oral H., Spinale F.G., Mann D.L. Pathophysiologically relevant concentrations of tumor necrosis factor-- promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998, 97:1382--391.
19. Braaten J.T., Scott F.W., Wood P.J., Riedel K.D., Wolynetz M.S., Brule D., Collins M.W. High beta--lucan oat bran and oat gum reduce postprandial blood glucose and insulin subjects with and without Type 2 diabetes. Diabetic Medicine 1994, 11:312--18.
20. Browder W., Williams D., Pretus H., Olivero G., Enrichens F., Mao P., Franchello A. Beneficial effect of enhanced macrophage function in the trauma patient. Annals of Surgery 1990, 211:605--13.
21. Brown G.D. Dectin--: a signalling non--LR pattern--ecognition receptor. Nature Reviews Immunology 2006, 6:33--3.
22. Brown G.D., Gordon S. Immune Recognition: A new receptor for beta--lucans. Nature 2001, 413:36--7.
23. Brown G.D., Gordon S. Fungal β--lucans and mammalian immunity. Immunity 2003, 19:311--15.
24. Brown G.D., Gordon S. Immune recognition of fungal beta--lucans. Cell Microbiology 2005, 7:471--79.
25. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S.J., Gordon S. Dectin-- mediates the biological effects of β--lucans. Journal of Experimental medicine 2003, 197:1119--124.
26. Brown G.D., Taylor P.R., Reid D.M., Willment J.A., Williams D.L., Martinez--omares L., Wong S.Y.C., Gordon S. Dectin-- is a major β--lucan receptor on macrophages. Journal of Experimental medicine 2002, 296:412.
27. Brown J., O'callaghan C., Marshall A., Gilbert R., Siebold C., Gordon S., Brown G., Jones E. Structure of the fungal beta--lucan--inding immune receptor dectin--: Implications for function. Protein Science 2007, 16:1042--052.
28. Bryant D., Becker L., Richardson J., Shelton J., Franco F., Peshock R., Thompson M., Giroir B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor--lpha. Circulation 1998, 97:1375--381.
29. Cantley L.C. The phosphoinositide 3--inase pathway. Science 2002, 296:1655--657.
30. Chen J., Seviour R. Medicinal importance of fungal beta--1--),(1--)--lucans. Mycology Research 2007, 111:635--52.
31. Chen Y.L. Effects of collagen and glucan on the healing of burn wounds in mice. Zhonghua Zheng Xing Shao Shang Wai Ke Za Shi 1992, 8:54--6.
32. Cheung N.K., Modak S., Vickers A., Knuckles B. Orally administered beta--lucans enhance anti--umor effects of monoclonal antibodies. Cancer Immunology and Immunotherapy 2002, 51:557--64.
33. Chihara G. Immunotherapeutic agents from plant origin. Springer Seminars in Immunopathology 1985, 8:387--00.
34. Chihara G. Preclinical evaluations of lentinan in animal models 1994, National Cancer Research Institute of Tokyo, 189--97.
35. Compton R., Williams D., Browder W. The beneficial effect of enhanced macrophage function on the healing of bowel anastomoses. The American Surgeon 1996, 62:14--8.
36. Cook J.A., Taylor D., Cohen C., Rodrigue J., Malshet V., Di Luzio N.R. Comparative evaluation of the role of macrophages and lymphocytes in mediating the antitumor action of glucan. Immune Modulation and Control of Neoplasia by Adjuvant Therapy 1978, 183--94. Raven Press, New York. M.A. Chirigos (Ed.).
37. Coppolino M.G., Dedhar S. Bi--irectional signal transduction by integrin receptors. International Journal of Biochemistry and Cell Biology 2000, 32:171--88.
38. Cramer D.E., Allendorf D.J., Baran J.T., Hansen R., Marroquin J., Li B., Ratajczak J., Ratajczak M.Z., Yan J. Beta--lucan enhances complement--ediated hematopoietic recovery after bone marrow injury. Blood 2006, 107:835--40.
39. Czop J.K. The role of β--lucan receptors in blood and tissue leukocytes in phagocytosis and metabolic activation. Pathology and immunopathology research 1986, 5:286--96.
40. Davis J.M., Murphy E.A., Brown A.S., Carmichael M.D., Ghaffar A., Mayer E.P. Effects of oat beta--lucan on innate immunity and infection after exercise stress. Medicine and science in sports and exercise 2005, 36:1321--327.
41. Delatte S.J., Evans J., Hebra A., Adamson W., Othersen H.B., Tagge E.P. Effectiveness of beta--lucan collagen for treatment of partial--hickness burns in children. Journal of Pediatric Surgery 2001, 36:113--18.
42. Dennehy K.M., Brown G.D. The role of the beta--lucan receptor Dectin-- in control of fungal infection. Journal of Leukocyte Biology 2007, 82:253--58.
43. Dennehy K.M., Ferwerda G., Faro--rindade I., Pyz E., Willment J.A., Taylor P.R., Kerrigan A., Tsoni S.V., Gordon S., Meyer--entrup F., Adema G.J., Kullberg B.J., Schweighoffer E., Tybulewicz V., Mora--ontes H.M., Gow N.A., Williams D.L., Netea M.G., Brown G.D. Syk kinase is required for collaborative cytokine production induced through Dectin-- and Toll--ike receptors. European Journal of Immunology 2008, 38:500--06.
44. Di Luzio N.R., Williams D.L., McNamee R.B., Edwards B.F., Kitahama A. Comparative tumor--nhibitory and anti--acterial activity of soluble and particulate glucan. International Journal of Cancer 1979, 24:773--79.
45. Di Luzio N.R., Williams D.L., Sherwood E.R., Browder I.W. Modification of diverse experimental immunosuppressive states by glucan. Survey of Immunologic Research 1985, 4:160--67.
46. Di Renzo L., Yefenof E., Klein E. The function of human NK cells is enhanced by β--lucan, a ligand of CR3 (CD11b/CD18). European Journal of Immunology 1991, 21:1755--758.
47. Diamond M.S., Garcia--guilar J., Bickford J.K., Corbi A.L., Springer T.A. The I domain is a major recognition site on the leukocyte integrin Mac-- (CD11b/CD18) for four distinct adhesion ligands. Journal of Cell Biology 1993, 120:1031--043.
48. Dritz S.S., Shi J., Kielian T.L., Goodband R.D., Nelssen J.L., Tokach M.D., Chengappa M.M., Smith J.E., Belcha F. Influence of dietary beta--lucan on growth performance, nonspecific immunity, and resistance to Streptococcus suis infection in weanling pigs. Journal of Animal Science 1995, 73:3341--350.
49. Dushkin M.I., Safina A.F., Vereschagin E.I., Schwartz Y.S. Carboxymethylated beta--,3--lucan inhibits the binding and degradation of acetylated low density lipoproteins in macrophages in vitro and modulates their plasma clearance in vivo. Cell Biochemistry and Function 1996, 14:209--17.
50. Ehlers M.R. CR3: a general purpose adhesion--ecognition receptor essential for innate immunity. Microbes and Infection 2000, 2:289--94.
51. Evans S.E., Hahn P.Y., McCann F., Kottom T.J., Pavlovic Z.V., Limper A.H. Pneumocystis cell wall beta--lucans stimulate alveolar epithelial cell chemokine generation through nuclear factor--appaB--ependent mechanisms. American journal of respiratory cell and molecular biology 2005, 32:490--97.
52. Fruman D.A., Cantley L.C. Phosphoinositide 3--inase in immunological systems. Seminars in Immunology 2002, 14:7--8.
53. Fukao T., Koyasu S. PI3K and negative regulation of TLR signaling. Trends in Immunology 2003, 24:358--63.
54. Fuller G.L.J., Williams J.A.E., Tomlinson M.G., Eble J.A., Hanna S.L., Poölmann S., Suzuki--noue K., Ozaki Y., Watson S.P., Pearce A.C. The C--ype lectin receptors CLEC-- and Dectin--, but not DC--IGN, signal via a novel YXXL--ependent signalling cascade. Journal of Biological Chemistry 2007, 282:12397--2409.
55. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., Underhill D.M. Collaborative induction of inflammatory responses by Dectin-- and toll--ike receptor 2. Journal of Experimental medicine 2003, 197:1107--117.
56. Gantner B.N., Simmons R.M., Underhill D.M. Dectin-- mediates macrophage recognition of Candida albicans yeast but not filaments. The EMBO Journal 2005, 24:1277--286.
57. Gersuk G.M., Underhill D.M., Zhu L., Marr K.A. Dectin-- and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. Journal of Immunology 2006, 176:3717--724.
58. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028--032.
59. Goodridge H.S., Simmons R.M., Underhill D.M. Dectin-- stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. Journal of Immunology 2007, 178:3107--115.
60. Gordon M., Deeks S., De Marzo C., Goodgame J., Guralnik M., Lang W., Mimura T., Pearce D., Kaneko Y. Curdlan sulfate (CRDS) in a 21--ay intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti--MV activity with low toxicity. Journal of Medicine 1997, 28:108--28.
61. Gordon M., Guralnik M., Kaneko Y., Mimura T., Baker M., Lang W. A phase I study of curdlan sulfate---n HIV inhibitor. Tolerance, pharmacokinetics and effects on coagulation and on CD4 lymphocytes. Journal of Medicine 1994, 25:163--80.
62. Gross O., Gewies A., Finger K., Schafer M., Sparwasser T., Peschel C., Forster I., Ruland J. Card9 controls a non--LR signalling pathway for innate anti--ungal immunity. Nature 2006, 442:651--56.
63. Gualde N., Rigaud M., Goodwin J.S. Induction of suppressor cells from peripheral blood T cells by 15--ydroperoxyeicosatetraenoic acid (15--PETE). Journal of Immunology 1985, 135:3424--429.
64. Guha M., Mackman N. The PI3K--kt pathway limits LPS activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. Journal of Biological Chemistry 2002, 277:32124--2132.
65. Ha T., Hua F., Grant D., Xia Y., Ma J., Gao X., Kelley J., Williams D.L., Kablfleisch J., Browder I.W., Li C. Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice. American Journal of Physiology: Heart and Circulatory Physiology 2006, 291:H1910--1918.
66. Hahn P.Y., Evans S.E., Kottom T.J., Standing J.E., Pagano R.E., Limper A.H. Pneumocystis carinii cell wall beta--lucan induces release of macrophage inflammatory protein-- from alveolar epithelial cells via a lactosylceramide--ediated mechanism. Journal of Biological Chemistry 2003, 278:2043--050.
67. Hamuro J., Chihara G. Lentinan, a T--ell--riented immunopotentiator: Its experimental and clinical applications and possible mechanism of immune modulation. Immune Modulation Agents and Their Mechanisms 1985, 409--36. Marcel Dekker, Inc., New York. R.L. Fenichel, M.A. Chirigos (Eds.).
68. Harler M.B., Wakshull E., Filardo E.J., Albina J.E., Reichner J.S. Promotion of neutrophil chemotaxis through differential regulation of beta 1 and beta 2 integrins. Journal of Immunology 1999, 162:6792--799.
69. Heinsbroek S.E.M., Taylor P.R., Rosas M., Willment J.A., Williams D.L., Gordon S., Brown G.D. Expression of functionally different Dectin-- isoforms by murine macrophages. Journal of Immunology 2006, 176:5513--518.
70. Herre J., Marshall A.S.J., Caron E., Edwards A.D., Williams D.L., Schweighoffer E., Tybulewicz V., Reis e Sousa C., Gordon S.E., Brown G.D. Dectin-- uses novel mechanisms for yeast phagocytosis in macrophages. Blood 2004, 104:4038--045.
71. Herre J., Willment J.A., Gordon S., Brown G.D. The role of Dectin-- in antifungal immunity. Critical Reviews in Immunolology 2004, 24:193--03.
72. Hohl T.M., Van Epps H.L., Rivera A., Morgan L.A., Chen P.L., Feldmesser M., Pamer E.G. Aspergillus fumigatus triggers inflammatory responses by stage--pecific beta--lucan display. PLOS Pathogens 2005, 1:e30.
73. Hong F., Hansen R.D., Yan J., Allendorf D.J., Baran J.T., Ostroff G.R., Ross G.D. Beta--lucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocyes as killer cells. Cancer Research 2003, 63:9023--031.
74. Hong F., Yan J., Baran J.T., Allendorf D.J., Hansen R.D., Ostroff G.R., Xing P.X., Cheung N.--.V., Ross G.D. Mechanism by which orally administered β--, 3--lucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. Journal of Immunology 2004, 173:797--06.
75. Ikeda Y., Adachi Y., Ishii T., Miura N., Tamura H., Ohno N. Dissociation of Toll--ike receptor 2--ediated innate immune response to Zymosan by organic solvent--reatment without loss of Dectin-- reactivity. Biological and Pharmaceutical Bulletin 2008, 31:13--8.
76. Ikeda Y., Adachi Y., Ishii T., Tamura H., Aketagawa J., Tanaka S., Ohno N. Blocking effect of anti--ectin-- antibodies on the anti--umor activity of 1,3--eta--lucan and the binding of Dectin-- to 1,3--eta--lucan. Biological and Pharmaceutical Bulletin 2007, 30:1384--389.
77. Iwabuchi K., Nagaoka I. Lackosylceramide--nriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. Blood 2002, 100:1454--464.
78. Jagodzinski P.P., Wiaderkiewicz R., Kurzawski G., Kloczewiak M., Nakashima H., Hyjek j.E., Yamamoto N., Uryu T., Kaneko Y., Posner M.R., et al. Mechanism of the inhibitory effect of curdlan sulfate on HIV--. Virology 1994, 202:735--45.
79. Janeway C.A. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunology Today 1992, 13:11--6.
80. Jimenez--ucho V., Ginsburg V., Krivan H.C. Cryptococcus neoformans, Candida albicans, and other fungi bind specifically to the Glycosphingolipic lactosylceramide (Galβ1--G1cβ1--Cer), a possible adhesion receptor for yeasts. Infection and Immunity 1990, 58:2085--090.
81. Jung K., Ha Y., Ha S.K., Han D.U., Kim D.W., Moon W.K., Chae C. Antiviral effect of Saccharomyces cerevisiae beta--lucan to swine influenza virus by increased production of interferon--amma and nitric oxide. Journal of veterinary medicine. B, Infectious diseases and veterinary public health 2004, 51:72--6.
82. Kapadia S., Dibbs Z., Kurrelmeyer K., Kalra D., Seta Y., Wang F., Buzkurt B., Oral H., Sivasubramanian N., Mann D.L. The role of cytokines in the failing human heart. Cardiology Clinics 1998, 16:645--56.
83. Karlsson K.A. Animal glycosphingolipids as membrane attachment sites for bacteria. Annual Review of Biochemistry 1989, 58:309--50.
84. Kato Y., Adachi Y., Ohno N. Contribution of N--inked oligosaccharides to the expression and functions of beta--lucan receptor, Dectin--. Biological and Pharmaceutical Bulletin 2006, 29:1580--586.
85. Kiechl S., Egger G., Mayr M., Wiedermann C.J., Bonora E., Oberhollenzer F., Muggeo M., Xu Q., Wick G., Poewe W., Willeit J. Chronic infections and the risk of carotid atherosclerosis. Circulation 2001, 103:1064.
86. Kougias P., Wei D., Rice P.J., Ensley H.E., Kalbfleisch J., Williams D.L., Browder I.W. Normal human fibroblasts express pattern recognition receptors for fungal (1→3)------lucans. Infection and Immunity 2001, 69:3933--938.
87. Kournikakis B., Mandeville R., Brousseau P., Ostroff G. Anthrax--rotective effects of yeast beta 1,3 glucans. Medscape General Medicine 2003, 5:1--0.
88. Kupfahl C., Geginat G., Hof H. Lentinan has a stimulatory effect on innate and adaptive immunity against murine Listeria monocytogenes infection. International Immunopharmacology 2007, 6:686--96.
89. Lanier L.L., Corliss B.C., Wu J., Leong C., Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine--ased activation motif is involved in activating NK cells. Nature 1998, 391:703--07.
90. LeBlanc B.W., Albina J.E., Reichner J.S. The effect of PGG--beta}--lucan on neutrophil chemotaxis in vivo. Journal of Leukocyte Biology 2006, 79:667--75.
91. Leibovich S.J., Danon D. Promotion of wound repair in mice by application of glucan. Journal of the Reticuloendothelial Society 1980, 27:1--1.
92. LeibundGut--andmann S., Groß O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J., e Sousa C.R. Syk--and CARD9--ependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nature Immunology 2007, 8:630--38.
93. Levy S., Shoham T. The tetraspanin web modulates immune--ignalling complexes. Nature Reviews Immunology 2005, 5:136--48.
94. Li B., Allendorf D.J., Hansen R., Marroquin J., Ding C., Cramer D.E., Yan J. Yeast beta--lucan amplifies phagocyte killing of iC3b--psonized tumor cells via complement receptor 3--yk--hosphatidylinositol 3--inase pathway. Journal of Immunology 2006, 177:1661--669.
95. Li B., Cramer D., Wagner S., Hansen R., King C., Kakar S., Ding C., Yan J. Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88--and Syk kinase--ependent pathways. Clinical Immunology 2007, 124:170--81.
96. Li C., Ha T., Kelley J., Gao X., Qiu Y., Kao R.L., Browder W., Williams D.L. Modulating Toll--ike receptor mediated signaling by (1→3)------lucan rapidly induces cardioprotection. Cardiovascular Research 2003, 61:538--47.
97. Li C., Kao R.L., Ha T., Kelley J., Browder I.W., Williams D.L. Early activation of IKKβ during in vivo myocardial ischemia. American Journal of Physiology: Heart and Circulatory Physiology 2001, 280:H1264--1271.
98. Liang J., Melican D., Cafro L., Palace G., Fisette L., Armstrong R., Patchen M.L. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG--lucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. International Journal of Immunopharmacology 1998, 20:595--14.
99. Lowe E., Rice P., Ha T., Li C., Kelley J., Ensley H., Lopez--erez J., Kalbfleisch J., Lowman D., Margl P., Browder W., Williams D. A (1--)------inked heptasaccharide is the unit ligand for glucan pattern recognition receptors on human monocytes. Microbes and Infection 2001, 3:789--97.
100. Lowe E.P., Wei D., Rice P.J., Li C., Kalbfleisch J., Browder I.W., Williams D.L. Human vascular endothelial cells express pattern recognition receptors for fungal glucans which stimulates nuclear factor ΚB activation and Interleukin 8 production. The American Surgeon 2002, 68:508--17.
101. Lyuksutova O.I., Murphey E.D., Toliver--insky T.E., Lin C.Y., Cui W., Williams D.L., Sherwood E.R. Glucan phosphate treatment attenuates burn--nduced inflammation and improves resistance to Pseudomonas Aeruginosa burn wound infection. Shock 2005, 23:224--32.
102. Mansell P.W.A., Di Luzio N.R. The in vivo destruction of human tumor by glucan activated macrophages. Role of Macrophage in Neoplasia 1976, 227--43. Academic Press, New York. M. Fink (Ed.).
103. Marchetti M., Pisani S., Pietropaolo V., Saganti L., Nicoletti R., Degener A., Orsi N. Antiviral effect of a polysaccharide from Sclerotium glucanicum towards herpes simplex virus type 1 infection. Planta Medica 1996, 62:303--07.
104. Mayberry W.R., Lane J.R. Sequential alkaline saponification/acid hydrolysis/esterification: a one--ube method with enhanced recovery of both cyclopropane and hydroxylated fatty acids. Journal of Microbiological Methods 1993, 18:21--2.
105. Medeiros A.C., Chacon D.A., Sales V.S., Egito E.S., Brandao--eto J., Pinheiro L.A., Carvalho M.R. Glucan and glutamine reduce bacterial translocation in rats subjected to intestinal ischemia--eperfusion. Journal of Investigative Surgery 2006, 19:39--6.
106. Meyer--entrup F., Figdor C.G., Ansems M., Brossart P., Wright M.D., Adema G.J., van Spriel A.B. Dectin-- interaction with tetraspanin CD37 inhibits IL-- production. Journal of Immunology 2007, 178:154--62.
107. Miura N.N., Ohno N., Aketagawa J., Tamura H., Tanaka S., Yadomae T. Blood clearance of (1→3)--eta----lucan in MRL lpr/lpr mice. FEMS Immunology and Medical Microbiology 1996, 13:51--7.
108. Mohagheghpour N., Dawson M., Hobbs P., Judd A., Winant R., Dousman L., Waldeck L., Hokama L., Tuse D., Kos F., et al. Glucans as immunological adjuvants. Advances in Experimental Medicine and Biology 1995, 383:13--2.
109. Monari C., Retini C., Casadevall A., Netski D., Bistoni F., Kozel T.R., Vecchiarelli A. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. European Journal of Immunology 2003, 33:1041--051.
110. Mueller A., Raptis J., Rice P.J., Kalbfleisch J.H., Stout R.D., Ensley H.E., Browder W., Williams D.L. The influence of glucan polymer structure and solution conformation on binding to (1→3)------lucan receptors in a human monocyte--ike cell line. Glycobiology 2000, 10:339--46.
111. Mueller A., Rice P.J., Ensley H.E., Coogan P.S., Kalbfleisch J.H., Kelley J.L., Love E.J., Portera C.A., Ha T., Browder I.W., Williams D.L. Receptor binding and internalization of water--oluble (1→3)--eta----lucan biologic response modifier in two monocyte/macrophage cell lines. Journal of Immunology 1996, 156:3418--425.
112. Murrin L.C., Talbot J.N. RanBPM, a scaffolding protein in the immune and nervous systems. Journal of Neuroimmune Pharmacology 2007, 2:290--95.
113. Nakamura K., Kinjo T., Saijo S., Miyazato A., Adachi Y., Ohno N., Fujita J., Kaku M., Iwakura Y., Kawakami K. Dectin-- is not required for the host defense to Cryptococcus neoformans. Microbiology and Immunology 2007, 51:1115--119.
114. Nakayama, H., Yoshizaki, F., Prinetti, A., Sonnino, S., Mauri, L., Takamori, K., Ogawa, H., & Iwabuchi, K. (2007). Lyn--oupled LacCer--nriched lipid rafts are requird for CD11b/CD18--ediated neutrophil phagocytosis of nonopsonized microorganisms. Journal of Leukocyte Biology, eprint.
115. Netea M.G., Brown G.D., Kullberg B.J., Gow N.A. An integrated model of the recognition of Candida albicans by the innate immune system. Nature Reviews. Microbiology 2008, 6:67--8.
116. Nicoletti A., Nicoletti G., Ferraro G., Palmieri G., Mattaboni P., Germogli R. Preliminary evaluation of immunoadjuvant activity of an orally administered glucan extracted from Candida albicans. Arzneimittelforschung 1992, 42:1246--250.
117. Ohno N., Suzuki I., Oikawa S., Sato K., Miyazaki T., Yadomae T. Antitumor activity and structural characterization of glucans extracted from cultured fruit bodies of Grifola frondosa. Chemical Pharmaceutical Bulletin 1984, 32:1142--151.
118. Olsson S., Sundler R. The macrophage beta--lucan receptor mediates arachidonate release induced by zymosan: essential role for Src family kinases. Molecular Immunology 2007, 44:1509--515.
119. Olynych T.J., Jakeman D.L., Marshall J.S. Fungal zymosan induces leukotriene production by human mast cells through a dectin----ependent mechanism. Journal of Allergy and Clinical Immunology 2006, 118:837--43.
120. Oral H., Kapadia S., Nakano M., Torre--mione G., Lee J., Lee--ackson D., Young J.B., Mann D.L. Tumor necrosis factor--lpha and the failing human heart. Clinical Cardiology 1995, 18:IV20--V27.
121. Ormstad H., Groeng E.C., Lovik M., Hetland G. The fungal cell wall component β--, 3--lucan has an adjuvant effect on the allergic response to ovalbumin in mice. Journal of Toxicology and Environmental Health, Part A 2000, 61:55--7.
122. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., Schroeder L., Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll--ike receptors. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:13766--3771.
123. Ozment--kelton T.R., Goldman M.P., Gordon S., Brown G.D., Williams D.L. Prolonged reduction of leukocyte membrane--ssociated Dectin-- levels following β--lucan administration. Journal of Pharmacolology and Experimental Therapeutics 2006, 318:540--46.
124. Palma A.S., Feizi T., Zhang Y., Stoll M.S., Lawson A.M., Diaz--odrigues E., Campanero--hodes M.A., Costa J., Gordon S., Brown G.D., Chai W. Ligands for the β--lucan receptor, Dectin--, assigned using 'designer' microarrays of oligosaccharides (neoglycolipids) generated from glucan polysaccharides. Journal of Biological Chemistry 2005, 281:5771--779.
125. Pearson A., Lux A., Kreieger M. Expression cloning of dSR--I, a class C macrophage--pecific scavenger receptor from Drosophila melanogaster. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:4056--060.
126. Persson W.K., Gronlund U., Johannisson A. Intramammary infusion of beta 1,3--lucan for prevention and treatment of Staphylococcus aureaus mastitis. Journal of veterinary medicine. B, Infectious diseases and veterinary public health 2003, 50:121--27.
127. Plow E.F., Zhang L. A MAC-- attack: integrin functions directly challenged in knockout mice. Journal of Clinical Investigation 1997, 99:1146.
128. Portera C.A., Love E.J., Memore L., Zhang L., Mueller A., Browder W., Williams D.L. Effect of macrophage stimulation on collagen biosynthesis in the healing wound. The American Surgeon 1997, 63:125--31.
129. Qiu H., Tang W., Tong X., Ding K., Zuo J. Structure elucidation and sulfated derivatives preparation of two alpha----lucans from Gastrodia elata Bl. and their anti--engue virus bioactivities. Carbohydrate Research 2007, 342:2230--236.
130. Rappleye C.A., Eissenberg L.G., Goldman W.E. Histoplasma capsulatum alpha--1,3)--lucan blocks innate immune recognition by the beta--lucan receptor. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:1366--370.
131. Reid D.M., Montoya M., Taylor P.R., Borrow P., Gordon S., Brown G.D., Wong S.Y. Expression of the beta--lucan receptor, Dectin--, on murine leukocytes in situ correlates with its function in pathogen recognition and reveals potential roles in leukocyte interactions. Journal of Leukocyte Biology 2004, 76:86--4.
132. Rice P.J., Adams E.L., Ozment--kelton T., Gonzalez A.J., Goldman M.P., Lockhart B.E., Barker L.A., Breuel K.F., DePonti W.K., Kalbfleisch J.H., Ensley H.E., Brown G.D., Gordon S., Williams D.L. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. Journal of Pharmacology and Experimental Therapeutics 2005, 314:1079--086.
133. Rice P.J., Kelley J.L., Kogan G., Ensley H.E., Kalbfleisch J.H., Browder I.W., Williams D.L. Human monocyte scavenger receptors are pattern recognition receptors for (1--)------lucans. Leukocyte Biology 2002, 72:140--46.
134. Rice P.J., Lockhart B.E., Barker L.A., Adams E.L., Ensley H.E., Williams D.L. Pharmacokinetics of fungal (1--)------lucans following intravenous administration in rats. International Immunopharmacology 2004, 4:1209--215.
135. Rogers N.C., Slack E.C., Edwards A.D., Nolte M.A., Schulz O., Schweighoffer E., Williams D.L., Gordon S., Tybulewicz V.L., Brown G.D., Reis e Sousa C. Syk--ependent cytokine induction by Dectin-- reveals a novel pattern recognition pathway for C type lectins. Immunity 2005, 22:507--17.
136. Ross G.D. Regulation of the adhesion versus cytotoxic functions of the Mac--/CR3/alphaMbeta2--ntegrin glycoprotein. Critical Reviews in Immunology 2000, 20:197--22.
137. 1. The Journal of Immunology 1985, 134:3307--315.
138. Ross G.D., Vetvicka V., Yan J., Xia Y., Vetvickova J. Therapeutic intervention with complement and beta--lucan in cancer. Immunopharmacology 1999, 42:61--4.
139. Rothfuchs A.G., Bafica A., Feng C.G., Egen J.G., Williams D.L., Brown G.D., Sher A. Dectin-- interaction with mycobacterium tuberculosis leads to enhanced IL--2p40 production by splenic dendritic cells. Journal of Immunology 2007, 179:3463--471.
140. Rylander R. Airway responsiveness and chest symptoms after inhalation of endotoxin or (1→3)--eta----lucan. Indoor Built Environment 1996, 5:106--11.
141. Rylander R., Lin R.H. (1--)------lucan --relationship to indoor air--elated symptoms, allergy and asthma. Toxicology 2000, 152:47--2.
142. Rylander R., Persson K., Goto H., Yuasa K., Tanaka S. Airborne Beta--,3--lucan may be related to symptoms in sick buildings. Indoor Environment 1992, 1:263--67.
143. Saijo S., Fujikado N., Furuta T., Chung S., Kotaki H., Seki K., Sudo K., Akira S., Adachi Y., Ohno N., Kinjo T., Nakamura K., Kawakami K., Iwakura Y. Dectin-- is required for host defense against Pneumocystic carinii but not against Candida albicans. Nature Immunology 2006, 8:39--6.
144. Sandvik A., Wang Y.Y., Morton H.C., Aasen A.O., Wang J.E., Johansen F.E. Oral and systemic administration of beta--lucan protects against lipopolysaccharide--nduced shock and organ injury in rats. Clinical and Experimental Immunology 2007, 148:168--77.
145. Schaeffer D.J., Krylov V.S. Anti--IV activity of extracts and compounds from algae and cyanobacteria. Ecotoxicology and Environmental Safety 2000, 45:208--27.
146. Slack E.C., Robinson M.J., Hernanz--alcon P., Brown G.D., Williams D.L., Schweighoffer E., Tybulewicz V.L., Reis e Sousa C. Syk--ependent ERK activation regulates IL-- and IL--0 production by DC stimulated with zymosan. European Journal of Immunology 2007, 37:1600--612.
147. Steele C., Marrero L., Swain S., Harmsen A.G., Zheng M., Brown G.D., Gordon S., Shellito J.D., Kolls J.K. Alveolar macrophage--ediated killing of Pneumocystic carinii f. sp. muris involves molecular recognition by the Dectin-- β--lucan receptor. Journal of Experimental medicine 2003, 198:1677--688.
148. Steele C., Rapaka R.R., Metz A., Pop S.M., Williams D.L., Gordon S., Kolls J.K., Brown G.D. The beta--lucan receptor Dectin-- recognizes specific morphologies of Aspergillus fumigatus. PLOS Pathogens 2005, 1:e42.
149. Stone B.A., Clarke A.E. Chemistry and biology of (1--)------lucan 1992, La Trobe University Press, Melbourne.
150. Suram S., Brown G.D., Ghosh M., Gordon S., Loper R., Taylor P.R., Akira S., Uematsu S., Williams D.L., Leslie C.C. Regulation of cytosolic phospholipase A2 activation and cyclooxgenase 2 expression in macrophages by the beta--lucan receptor. Journal of Biological Chemistry 2006, 281:5506--514.
151. Suzuki I., Hashimoto K., Ohno N., Tanaka H., Yadomae T. Immunomodulation by orally administered beta--lucan in mice. International Journal of Immunopharmacology 1989, 11:761--69.
152. Suzuki I., Tanaka H., Kinoshita A., Oikawa S., Osawa M., Yadomae T. Effect of orally administered beta--lucan on macrophage function in mice. International Journal of Immunopharmacology 1990, 12:675--84.
153. Suzuki M., Takatsuki F., Maeda Y.Y., Hamuro J., Chihara G. Antitumor and immunological activity of lentinan in comparison with LPS. International Journal of Immunopharmacology 1996, 16:463--68.
154. Takahashi T., Fujisaki M., Hirahata S., Maeda D., Tokura H., Ohyama T., Irino T. A case of advanced gastric cancer with multiple liver metastases successfully treated with TS--/low dose CDDP/lentinan combination chemotherapy. Gan To Kagaku Ryoho 2006, 33:2061--063.
155. Taylor P.R., Brown G.D., Reid D.M., Willment J.A., Martinez--omares L., Gordon S., Wong S.W.C. The β--lucan receptor, Dectin--, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. Journal of Immunology 2002, 169:3876--882.
156. Taylor P.R., Tsoni S.V., Willment J.A., Dennehy K.M., Rosas M., Findon H., Haynes K., Steele C., Botto M., Gordon S., Brown G.D. Dectin-- is required for β--lucan recognition and control of fungal infection. Nature Immunology 2006, 8:31--8.
157. Thorn J., Beijer L., Rylander R. Effects after inhalation of (1--)------lucan in healthy humans. Mediators of Inflammation 2001, 10:173--78.
158. Thornton B.P., Vetvicka V., Pitman M., Goldman R.C., Ross G.D. Analysis of the sugar specificity and molecular location of the beta--lucan--inding lectin site of complement receptor type 3 (CD11b/CD18). The Journal of Immunology 1996, 156:1235--246.
159. Torre--mione G., Kapadia S., Lee J., Durand J.B., Bies R.D., Young J.B., Mann D.L. Tumor necrosis factor--lpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996, 93:704--11.
160. Tsikitis V.L., Morin N.A., Harrington E.O., Albina J.E., Reichner J.S. The lectin--ike domain of complement receptor 3 protects endothelial barrier function from activated neutrophils. Journal of Immunology 2004, 173:1284--291.
161. Underhill D.M., Ozinsky A., Hajjar A.M., Stevens A., Wilson C.B., Bassetti M., Aderem A. The toll--ike receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999, 401:811--15.
162. Underhill D.M., Rossnagle E., Lowell C.A., Simmons R.M. Dectin-- activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 2005, 106:2543--550.
163. Uryu T. Sulfated curdlan and sulfated alkyl oligosaccharide as anti--iral agent. Nippon Rinsho 1993, 51:164--68.
164. van den Herik--udijk I.E., Capel P.J., van der Bruggen T., van de Winkel J.G. Identification of signaling motifs within human Fc gamma RIIa and Fc gamma RIIb isoforms. Blood 1995, 84:2202--211.
165. Vereschagin E.I., Van Lambalgen A.A., Dushkin M.I., Schwartz Y.S., Polyakov L., Heemskerk A., Huisman E., Thijs L.G., Van den Bos G.C. Soluble glucan protects against endotoxin shock in the rat: The role of the scavenger receptor. Shock 1998, 9:193--98.
166. Vetvicka V., Thornton B.P., Ross G.D. Soluble beta--lucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b--psonized target cells. Journal of Clinical Investigation 1996, 98:50--1.
167. Viriyakosol S., Fierer J., Brown G.D., Kirkland T.N. Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll--ike receptor 2 and Dectin--. Infection and Immunity 2005, 73:1553--560.
168. Wakshull E., Brunke--eese D., Lindermuth J., Fisette L., Nathans R.S., Crowley J.J., Tufts J.C., Zimmerman J., Mackin W., Adams D.S. PGG--lucan, a soluble beta--1,3)--lucan, enhances the oxidative burst response, microbicidal activity, and activates an NF--appaB--ike factor in human PMN: evidence for a glycosphingolipid beta--1,3)--lucan receptor. Immunopharmacology 1999, 41:89--07.
169. Wang S.C., Bligh S.W., Shi S.S., Wang Z.T., Hu Z.B., Crowder J., Branford--hite C., Vella C. Structural features and anti--IV-- activity of novel polysaccharides from red algae Grateloupia longifolia and Grateloupia filicina. International Journal of Biological Macromolecules 2007, 41:369--75.
170. Wei D., Williams D., Browder W. Activation of AP-- and SP1 correlates with wound growth factor gene expression in glucan--reated human fibroblasts. International Immunopharmacology 2002, 2:1163--172.
171. Wei D., Zhang L., Williams D.L., Browder I.W. Glucan stimulates human dermal fibroblast collagen biosynthesis through a nuclear factor-- dependent mechanism. Wound Repair and Regeneration 2002, 10:161--68.
172. Wheeler R.T., Fink G.R. A drug--ensitive genetic network masks fungi from the immune system. PLOS Pathogens 2006, 2:e35.
173. Williams D.L. Overview of (1→3)-β-d--glucan immunobiology. Mediators of Inflammation 1997, 6:247--50.
174. Williams D.L., Browder I.W., DiLuzio N.R. Immunotherapeutic modification of Escherichia coli--nduced experimental peritonitis and bacteremia by glucan. Surgery 1983, 93:448--54.
175. Williams D.L., Cook J.A., Hoffmann E.O., DiLuzio N.R. Protective effect of glucan in experimentally induced candidiasis. Journal of the Reticuloendothelial Society 1978, 23:479--90.
176. Williams D.L., Di Luzio N.R. Glucan induced modification of experimental Staphylococcus aureus infection in normal, leukemic and immunosuppressed mice. Macrophages and Lymphocytes, Part A 1980, 291--06. Plenum Publishing Corporation, New York. M.R. Escobar, H. Friedman (Eds.).
177. Williams D.L., Di Luzio N.R. Immunopharmacologic modification of experimental viral diseases by glucan. EOS --Rivista di immunologia ed immunofarmacologia 1985, 2:78--2.
178. Williams D.L., Di Luzio N.R. Immunopharmacologic modification of experimental viral diseases by glucan. EOS Journal of Immunology and Immunopharmacology 1985, 5:78--2.
179. Williams D.L., DiLuzio N.R. Glucan--nduced modification of murine viral hepatitis. Science 1980, 208:67--9.
180. Williams D.L., Ha T., Li C., Kalbfleisch J.H., Ferguson D.A. Early activation of hepatic NFkB and NF--L6 in polymicrobial sepsis correlates with bacteremia, cytokine expression and mortality. Annals of Surgery 1999, 230:95--04.
181. Williams D.L., Ha T., Li C., Kalbfleisch J.H., Laffan J.J., Ferguson D.A. Inhibiting early activation of tissue nuclear factor--B and nuclear factor interleukin 6 with (1→3)------lucan increases long--erm survival in polymicrobial sepsis. Surgery 1999, 126:54--5.
182. Williams D.L., Ha T., Li C., Kalbfleisch J.H., Schweitzer J., Vogt W., Browder I.W. Modulation of tissue toll--ike receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Critical Care Medicine 2003, 31:1808--818.
183. Williams D.L., Ha T., Li C., Laffan J., Kalbfleisch J., Browder W. Inhibition of LPS induced NFκB activation by a glucan ligand involves down regulation of IKKβ kinase activity and altered phosphorylation and degradation of IκBα. Shock 2000, 13:446--52.
184. Williams D.L., Li C., Ha T., Ozment--kelton T., Kalbfleisch J.H., Preiszner J., Brooks L., Breuel K., Schweitzer J.B. Modulation of the phosphoinositide 3--inase pathway alters innate resistance to polymicrobial sepsis. Journal of Immunology 2004, 172:449--56.
185. Williams D.L., Lowman D.W., Ensley H.E. Introduction to the chemistry and immunobiology of β--lucans. Toxicology of 1→3--eta--lucans. Glucans as a marker for fungal exposure 2004, 1--4. Taylor & Francis, New York. S.H. Young, V. Castranova (Eds.).
186. Williams D.L., Mueller A., Browder W. Glucan--ased macrophage stimulators: A review of their anti--nfective potential. Clinical Immunotherapy 1996, 5:392--99.
187. Williams D.L., Ozment--kelton T., Li C. Modulation of the phosphoinositide----inase signaling pathway alters host resistance to sepsis, inflammation, and ischemia/reperfusion injury. Shock 2006, 25:432--39.
188. Williams D.L., Pretus H.A., McNamee R.B., Jones E.L., Ensley H.E., Browder I.W., Di Luzio N.R. Development, physicochemical characterization and preclinical efficacy evaluation of a water soluble glucan sulfate derived from Saccharomyces cerevisiae. Immunopharmacology 1991, 22:139--56.
189. Williams D.L., Rice P.J., Herre J., Willment J.A., Taylor P.R., Gordon S., Brown G.D. Recognition of fungal glucans by pattern recognition receptors. Recent Developments in Carbohydrate Research 2003, 1:49--6.
190. Williams D.L., Yaeger R.G., Pretus H.A., Browder I.W., McNamee R.B., Jones E.L. Immunization against Trypanosoma cruzi: Adjuvant effect of glucan. International Journal of Immunopharmacology 1989, 11:403--10.
191. Willment J.A., Gordon S., Brown G.D. Characterization of the human β--lucan receptor and its alternatively spliced isoforms. Journal of Biological Chemistry 2001, 276:43818--3823.
192. Willment J.A., Lin H.--., Reid D.M., Taylor P.R., Williams D.L., Wong S.Y.C., Gordon S., Brown G.D. Dectin-- expression and function are enhanced on alternatively activated and GM--SF--reated macrophages and are negatively regulated by IL--0, dexamethasone, and lipopolysaccharide. Journal of Immunology 2003, 171:4569--573.
193. Willment J.A., Marshall A.S.J., Reid D.M., Williams D.L., Wong S.Y.C., Gordon S., Brown G.D. The human β--lucan receptor is widely expressed and functionally equivalent to murine Dectin-- on primary cells. European Journal of Immunology 2005, 1539.
194. Wolk M., Danon D. Promotion of wound healing by yeast glucan evaluated on single animals. Medical Biology 1985, 63:73--0.
195. Wright S.D., Silverstein S.C. Tumor--romoting phorbol esters stimulate C3b and C3b' receptor--ediated phagocytosis in cultured human monocytes. Journal of Experimental medicine 1982, 156:1149--164.
196. Wu D.Y., Han S.N., Bronson R.T., Smith D.E., Meydani S.N. Dietary supplementation with mushroom--erived protein--ound glucan does not enhance immune function in young and old mice. Journal of Nutrition 1998, 128:193--97.
197. Wuersch P., Pi--unyer F.X. The role of viscous soluble fiber in the metabolic control of diabetes --a review with special emphasis on cereals rich in beta--lucan. Diabetes Care 1997, 20:1774--780.
198. Xia Y., Borland G., Huang J., Mizukami I.F., Petty H.R., Todd R.F., Ross G.D. Function of the lectin domain of Mac--/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion. Journal of Immunology 2002, 169:6417--426.
199. Xia Y., Vetvicka V., Yan J., Hanikyrova M., Mayadas T., Goss G.D. The beta--lucan--inding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b--psonized target cells. Journal of Immunology 1999, 162:2281--290.
200. Xie J., Sun M., Guo L., Liu W., Jiang J., Chen X., Zhou L., Gu J. Human Dectin-- isoform E is a cytoplasmic protein and interacts with Ran BPM. Biochemical and Biophysical Research Communications 2006, 347:1067--073.
201. Yadav M., Schorey J.S. The β--lucan receptor Dectin-- functions together with TLR2 to mediated macrophage activation by mycobacteria. Blood 2006, 108:3168--175.
202. Yan J., Allendorf D.J., Brandley B. Yeast whole glucan particle (WGP) beta--lucan in conjunction with antitumour monoclonal antibodies to treat cancer. Expert Opinion on Biological Therapy 2005, 5:691--02.
203. Yan J., Vetvicka V., Xia Y., Coxon A., Carroll M.C., Mayadas T.N., Ross G.D. β--lucan, a "Specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor Type 3 (CD11b/CD18). Journal of Immunology 1999, 163:3045--052.
204. Yoshida M., Roth R.I., Grunfeld C., Feingold K.R., Levin J. Soluble (1--)--eta----lucan purified from Candida albicans: Biologic effects and distribution in blood and organs in rabbits. Journal of Laboratory Clinical Medicine 1996, 128:103--14.
205. Yoshida M., Roth R.I., Grunfeld C., Feingold K.R., Levin J. Pharmacokinetics, biological effects, and distribution of (1→3)------lucan in blood and organs in rabbits. Mediators of Inflammation 1997, 6:279--83.
206. Yoshitomi H., Sakaguchi N., Kobayashi K., Brown G.D., Tagami T., Sakihama T., Hirota K., Tanaka S., Nomura T., Miki I., Gordon S., Akira S., Nakamura T., Sakaguchi S. A role for fungal {beta}--lucans and their receptor Dectin-- in the induction of autoimmune arthritis in genetically susceptible mice. Journal of Experimental medicine 2005, 201:949--60.
207. Zakany J., Chihara G., Fachet J. Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts. International Journal of Cancer 1980, 25:371--76.
208. Zelensky A.N., Gready J.E. The C--ype lectin--ike domain superfamily. FEBS Journal 2005, 272:6179--217.
209. Zimmerman J.W., Lindermuth J., Fish P.A., Palace G.P., Stevenson T.T., DeMong D.E. A novel carbohydrate--lycosphingolipid interaction between a beta--1--)--lucan immunomodulator, PGG--lucan, and lactosylceramide of human leukocytes. Journal of Biological Chemistry 1998, 273:22014--2020.